Diebold Nixdorf (DBD) Stock: Buy, Sell, or Hold?
DBD - Diebold Nixdorf, Incorporated
$68.16
0.32 (0.47%)
▲
5d:
+6.02%
30d:
+5.85%
90d:
-21.64%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 28, 2026
5d
Get Alerted When DBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DBD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DBD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$159.94
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$99.31
31.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DBD is currently trading at $68.16, which is considered extended relative to its 30-day fair value range of $62.28 to $66.20. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.7) compared to its historical average (11.7). Remarkably, the market is currently pricing in an annual earnings decline of 5.9% over the next few years. This pessimistic expectation contrasts with the company's recent 34.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DBD is in a strong downtrend. The price is approaching resistance at $69.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DBD scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $98.33 (+44.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DBD is in a strong downtrend. The price is approaching resistance at $69.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DBD scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $98.33 (+44.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$62.28 -
$66.20
Company Quality Score
36/100
(SELL)
Options IV Signal
40th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
36.5%
Protect Your Profits
Holding DBD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 40th percentile)
- BEARISH: Weak technical setup (34/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.3% below Wall St target ($98.33)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$62.28 -
$66.20
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$4.57
(6.7%)
Support & Resistance Levels
Support Level
$62.58
Resistance Level
$69.10
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.71
Wall Street Target
$98.33
(+44.3%)
Revenue Growth (YoY)
1.7%
Earnings Growth (YoY)
34.2%
Profit Margin
2.9%
Valuation Discount vs History
-5.9% cheaper
PE vs Historical
9.7 vs 11.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.9%
(market-implied from PE analysis)
1-Year Target
$64.14
(-6%)
2-Year Target
$60.35
(-12%)
3-Year Target
$56.79
(-17%)
3-Yr Target (if PE normalizes)
(PE: 10→12)
$68.44
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 30.6%)
$310.89
(+356%)
Base:
(SPY PE: 9.7, Growth: 30.6%)
$151.99
(+123%)
Bear:
(PE: 8.3, Growth: 30.6%)
$129.19
(+90%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 22.39 | Current EPS (TTM): $3.03
Bull Case
$149.25
(+119%)
Analyst growth 100.0%, PE expands to 24.6
Base Case
$135.68
(+99%)
Market implied 100.0%, PE stable at 22.4
Bear Case
$46.13
(-32%)
Severe decline -20.0%, PE contracts to 19.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.7 to 11.7
Stabilization Target:
$82.13
(+20.5%)
PE Expansion Potential:
+20.5%
Share & Embed Analysis
Last updated: October 22, 2026 5:54 AM ET
Data refreshes hourly during market hours. Next update: 6:54 AM
Data refreshes hourly during market hours. Next update: 6:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DBD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Software - Application Stocks
Top-rated stocks in Software - Application by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NOW
ServiceNow Inc |
STRONG BUY
49 analysts |
$152 | 39 SELL |
|
GRAB
Grab Holdings Ltd |
STRONG BUY
24 analysts |
$6 | 55 HOLD |
|
SHOP
Shopify Inc |
STRONG BUY
54 analysts |
$176 | 38 SELL |
|
FROG
Jfrog Ltd |
STRONG BUY
23 analysts |
$112 | 57 HOLD |
|
ADSK
Autodesk Inc |
STRONG BUY
36 analysts |
$308 | 30 SELL |
Advanced DBD Option Strategies
Professional options setups generated by AI based on today's DBD price and gamma walls.
